SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-14-001465
Filing Date
2014-03-28
Accepted
2014-03-28 08:00:27
Documents
10
Period of Report
2014-05-09
Effectiveness Date
2014-03-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_032814.htm DEF 14A 870933
2 logo.jpg GRAPHIC 4936
3 greenleaf.jpg GRAPHIC 23511
4 knapp.jpg GRAPHIC 20497
5 notice_1.jpg GRAPHIC 115858
6 notice_2.jpg GRAPHIC 198226
7 notice_3.jpg GRAPHIC 70991
8 notice_4.jpg GRAPHIC 41780
9 card_1.jpg GRAPHIC 234919
10 card_2.jpg GRAPHIC 198078
  Complete submission text file 0001171843-14-001465.txt   2125112
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33609 | Film No.: 14723302
SIC: 2834 Pharmaceutical Preparations